AMEDISYS INC AMED Cash Flow

Amedisys inc (AMED)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09
Cash Flows from Operating Activities:
Net income
32,046	27,969	34,325	34,040	31,573	27,720	31,548	33,541	27,320	-3,706	14,661	4,529	15,199	8,972	11,501	10,843	6,315	13,072	8,575	10,873	-34,832	9,331	8,597	7,671	-12,510	-9,978	-91,777	1,847	2,133	-122,007	9,995	7,966	5,463	4,320	-423,697	21,711	15,324	22,269	21,808	32,366	36,830	38,039	36,024	35,123	27,037
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
5,338	5,988	4,366	5,179	2,895	3,379	3,164	3,125	3,593	3,984	4,185	4,537	4,417	5,016	5,214	4,975	4,473	4,238	4,646	4,615	6,537	6,198	6,515	7,698	7,936	8,653	9,051	9,556	10,123	10,013	9,975	9,905	10,166	10,652	9,826	9,726	9,355	9,292	8,832	8,279	8,186	7,630	7,481	6,919	6,282
Provision for doubtful accounts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,471	4,253	3,940	4,683	3,638	2,756	2,976	2,977	4,182	4,242	4,968	3,608	4,131	4,755	3,967	5,442	5,665	4,708	5,913	3,790	4,628	2,128	3,162	5,145	5,261	4,463	4,345	3,697	4,578	5,737	6,166
Non-cash compensation
5,909	6,549	6,298	5,538	6,615	5,247	4,842	3,767	4,044	4,512	3,558	4,356	3,874	3,845	4,750	3,736	4,070	4,187	3,060	2,193	2,384	2,400	1,697	1,069	431	1,586	1,653	1,224	2,056	1,152	1,285	2,298	2,482	27	3,150	3,205	1,910	2,317	2,636	3,168	2,513	2,108	820	2,779	2,141
401(k) employer match
3,291	2,964	2,859	2,307	2,379	2,042	2,040	2,327	2,567	2,207	2,180	2,140	2,227	1,741	1,694	1,703	1,737	1,545	1,090	1,641	1,813	1,534	1,634	1,656	1,392	1,798	1,837	2,123	2,240	2,438	2,535	2,693	2,347	1,705	2,513	1,929	1,403	5,226	6,069	5,762	5,705	5,256	4,246	5,051	4,530
Amortization and impairment of operating lease right of use assets
9,058	8,891	9,519	9,150	8,345	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss (gain) on disposal of property and equipment
-55	-135	-8	-2	4	24	-88	-87	-563	-22	169	-163	16	-26	-34	-162	-360	170	-415	-334	-196	-418	-1,486	-2,356	-332	-1,503	-531	-497	-211	-405	-218	-343	-505	-644	-483	-657	-656	-922	-295	-1,848	-171	-229	-58	-437	-98
Write-off of other comprehensive income
15	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of care centers
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	2,322	645	-56	1,451	357	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred income taxes
1,228	-4,298	11,923	2,606	3,269	5,384	5,771	6,200	2,945	34,972	9,646	-1,863	9,445	5,811	7,327	7,324	4,038	8,870	5,241	7,377	-22,165	16,204	9,374	4,782	-7,799	-3,484	-56,570	4,246	-1,287	-39,760	3,042	5,080	477	11,221	-137,331	3,309	399	25,627	-5,774	4,451	1,623	9,870	6,523	4,013	1,141
Equity in earnings from equity method investments
477	1,218	-812	3,716	1,216	1,231	1,625	2,976	1,860	232	900	2,355	-106	1,986	3,244	363	-5	1,122	1,924	4,826	1,951	757	563	884	787	466	354	337	363	604	390	396	305	380	325	466	323	706	788	734	788	622	655	642	424
Amortization of deferred debt issuance costs/debt discount
220	220	220	220	213	201	241	177	178	180	185	185	185	185	185	185	185	185	221	277	276	276	238	142	141	151	178	177	193	260	394	394	394	394	394	394	394	394	394	394	394	394	394	394	394
Return on equity investment
2,369	1,228	2,885	117	725	1,785	2,169	1,579	625	665	1,240	3,266	150	2,410	1,551	0	362	475	497	3,993	645	525	800	300	400	675	575	0	400	525	425	475	150	550	548	780	-240	3,155	-550	-750	-90	-	-	-	-
Asset impairment charge
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	2,075	0	75,193	899	0	0	2,208	5,664	1,542	2,286	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities, net of impact of acquisitions:
Patient accounts receivable
25,459	-15,323	15,304	1,832	22,333	-6,058	-2,562	4,656	-8,260	23,826	4,013	681	6,152	-10,107	15,758	2,660	27,689	4,705	14,927	2,559	14,302	-558	-3,892	555	9,185	3,592	-9,486	-15,139	-20,545	11,154	5,964	6,036	19,686	643	2,563	-216	3,536	10,244	-10,145	5,747	4,648	-23,355	8,690	24,577	-15,112
Other current assets
5,756	-7,512	1,851	-2,292	10,635	-8,711	-11,648	4,698	6,982	-956	-996	3,489	3,403	-3,361	4,681	2,294	-7,845	6,246	-8,852	-7,526	3,677	4,384	-330	-4,122	6,337	1,910	-4,287	-5,542	8,420	-7,747	-2,464	924	-1,335	10,993	1,157	-5,005	-5,112	14,270	-4,995	-6,316	-4,940	13,581	3,435	-5,001	2,981
Other assets
-417	-630	-258	-282	338	-2,221	-38	-642	-46	547	11,054	158	990	-494	-34	9,168	2,775	2,720	-357	146	1,014	-140	-354	-2,419	1,219	-473	1,269	283	517	444	-62	506	39	-4,046	-2,060	5,871	493	206	-734	3,154	-239	-4,257	155	2,282	-507
Accounts payable
-2,673	-3,184	1,330	1,665	-11,140	3,835	-4,293	5,146	-1,523	2,587	-6,523	1,000	93	-3,338	-1,300	-490	9,098	-958	2,434	-1,993	8,156	-3,836	254	-3,077	3,491	-1,765	-148	-7,018	-945	7,878	-1,263	1,544	-87	-2,335	1,171	-3,246	2,889	1,411	-2,173	2,164	3,204	-1,898	1,818	1,853	-99
Accrued expenses
-13,627	14,193	-1,359	10,424	18,838	-1,234	10,210	6,355	-1,807	9,259	25,327	-4,129	1,386	1,482	-6,289	-3,612	801	-746	4,963	9,870	-5,681	7,576	-10,039	-3,633	9,591	5,094	-6,905	-6,283	1,990	-9,179	-6,839	-6,027	2,051	6,524	-3,873	-15,207	17,605	-13,756	-5,698	-7,217	8,858	-7,380	14,396	14,741	-5,252
Other long-term obligations
3,060	-98	-50	-37	-144	-19	115	-1	2,348	-140	-406	31	576	-576	314	57	-521	-543	-838	623	-71	-464	-3,897	-115	1,250	214	3,088	447	90	240	157	-339	-239	1,554	-2,161	169	-1,543	-131	-112	1,288	-625	28	186	2,676	-167
Operating lease liabilities
-8,132	-8,179	-7,916	-8,061	-8,139	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating lease right of use assets
-817	-881	-868	-910	-844	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by operating activities
6,035	75,220	47,455	59,266	20,059	64,033	68,480	50,653	40,317	32,189	10,201	36,244	27,097	28,561	6,803	14,651	12,244	20,044	30,704	42,554	14,483	4,595	25,342	-89,129	-6,342	8,401	27,885	33,561	32,416	15,628	21,761	21,178	10,927	36,917	27,780	23,959	52,554	33,665	47,174	54,397	71,037	28,737	88,624	75,813	54,485
Cash Flows from Investing Activities:
Proceeds from sale of deferred compensation plan assets
16	161	74	5	208	152	92	9	462	0	57	0	565	0	0	0	230	152	51	962	64	2	4	5	0	0	28	29	71	73	0	9	230	126	6	0	853	-	-	-	-	0	0	600	356
Proceeds from the sale of property and equipment
12	4	12	81	65	3	40	6	5	131	118	0	0	-	-	-	-	-	-	-	-	-	-	-	-	1,683	0	65	61	22	19	590	0	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of deferred compensation plan assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	19	28	37	34	33	18	19	45	29	20	28	80	47	73	93	160	219	36	35	964	54	43	95	2,515	454
Purchases of property and equipment
1,434	1,551	3,644	1,495	1,198	874	4,073	149	1,462	1,633	1,625	3,064	4,385	2,215	3,587	3,213	6,702	3,460	1,301	14,555	2,113	2,126	814	3,536	5,532	12,753	9,388	9,521	10,074	16,064	11,957	10,005	10,236	5,842	12,541	9,452	16,580	26,436	13,625	13,944	9,966	10,361	10,942	7,578	7,478
Investments in equity method investees
0	0	0	90	120	3,667	3,477	0	0	40	0	180	256	290	318	432	0	-	-	-	-	-	-	-	-	335	3,505	0	6,227	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions of businesses, net of cash acquired
69,349	0	46	17,547	327,867	5,186	0	1,824	2,250	9,587	0	20,029	4,099	4,144	3,744	-48	27,682	63,330	5,800	0	0	-	-	-	-	1,000	0	0	627	3,755	352	8,392	0	-	-	-	-	700	400	752	1,969	22,080	12,287	11,715	7,490
Proceeds from disposition of care centers
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	2,000	1,588	645	1,421	1,643	2,082	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions of reacquired franchise rights
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-1	0	2,377	-	-	-	-
Net cash used in investing activities
-70,755	-1,386	-3,604	-19,046	-328,912	-9,572	-7,418	-1,958	-3,245	-11,129	-1,450	-23,273	-8,175	-6,649	-7,649	-3,597	-34,154	-47,562	-8,037	-9,754	-2,068	-5,138	230	-4,472	-4,920	-11,002	-11,241	-7,390	-16,825	-19,744	-12,318	-17,878	-10,053	-12,047	-17,128	-135,589	-15,946	-31,956	-13,974	-13,320	-14,366	-32,484	-23,286	-26,419	-15,066
Cash Flows from Financing Activities:
Outstanding checks in excess of bank balance
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,126	-43	-3,692	313
Proceeds from issuance of stock upon exercise of stock options
1,184	223	2,045	987	356	3,204	140	2,484	125	340	11	3,550	653	0	0	0	0	0	204	14	181	475	1	-1	89	3	145	113	0	-	-	-	-	0	9	140	96	7	136	419	939	2,806	512	29	425
Proceeds from issuance of stock to employee stock purchase plan
860	803	850	752	782	642	630	560	597	584	611	575	612	665	611	569	638	613	532	555	504	558	551	667	657	745	741	858	837	979	956	1,016	962	1,188	1,230	1,153	1,578	1,514	1,678	1,567	1,445	1,261	1,347	1,512	1,222
Shares withheld upon stock vesting
4,050	171	4,895	1,802	2,688	1,149	2,589	1,527	1,305	485	728	4,968	758	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax benefit from stock options exercised and restricted stock vesting
-	-	-	-	-	-	-	-	-	-	-	-	-	0	111	6,971	159	2,073	0	0	0	-	-	-	5	-	-	-	0	-	-	-	-	-427	93	416	-82	-41	235	1,478	714	659	210	-35	672
Noncontrolling interest distribution
360	152	453	91	366	560	180	322	28	0	126	48	42	45	84	200	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from borrowings under term loan
0	0	0	0	175,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from borrowings under revolving line of credit
187,500	70,000	8,000	23,000	161,500	10,500	0	127,500	0	-	-	-	-	6,000	44,500	43,500	40,500	0	0	22,600	40,800	41,000	0	146,800	54,000	0	0	13,000	12,500	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Repayments of borrowings under revolving line of credit
37,500	67,000	41,000	58,000	34,000	60,500	70,000	0	0	-	-	-	-	6,000	44,500	58,500	25,500	0	0	22,600	55,800	36,000	95,000	41,800	54,000	0	0	13,000	12,500	0	0	0	0	-	-	-	-	-	-	-	-	0	11,000	88,500	31,200
Principal payments of long-term obligations
1,592	1,804	1,543	1,718	559	379	596	87,656	2,819	1,250	1,569	1,250	1,250	1,250	1,250	1,250	1,250	0	97,000	3,000	3,000	3,000	3,277	3,675	3,952	23,951	3,952	3,952	23,952	78,952	8,451	8,488	8,550	7,811	10,098	9,949	9,627	10,812	11,443	10,309	12,274	10,528	12,102	9,458	12,250
Debt issuance costs
0	-47	0	0	847	0	0	2,433	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from revolving line of credit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	26,000	24,200
Purchase of company stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-15	0	0	12,315	4,581	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
146,042	1,899	-36,996	-36,872	299,178	-48,242	-72,956	-142,796	-3,430	-811	-1,801	-2,141	-785	-630	-207	-8,910	2,232	-2,031	1,183	-2,731	-17,315	3,033	-31,255	101,986	-3,201	-23,722	-3,136	-3,074	-23,115	-20,445	-7,495	-7,432	-7,588	-6,328	-9,322	-9,106	-8,035	-9,451	-21,190	-7,030	-9,176	-6,928	-21,076	-74,144	-16,618
Net increase (decrease) in cash, cash equivalents and restricted cash
81,322	75,733	6,855	3,348	-9,675	6,219	-11,894	-94,101	33,642	20,249	6,950	10,830	18,137	21,282	-1,053	2,144	-19,678	-29,549	23,850	30,069	-4,900	2,490	-5,683	8,385	-14,463	-26,323	13,508	23,097	-7,524	-24,561	1,948	-4,132	-6,714	18,542	1,330	-120,736	28,573	-7,742	12,010	34,047	47,495	-10,675	44,262	-24,750	22,801
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest
1,755	1,872	3,569	3,462	725	533	909	1,015	1,065	509	1,016	466	706	621	917	711	648	577	2,000	1,771	1,827	2,831	1,797	2,549	425	1,606	378	377	1,629	883	3,402	106	3,388	246	3,438	166	3,490	390	3,683	531	3,735	454	3,965	886	5,034
Cash paid for income taxes, net of refunds received
5,272	11,866	9,807	7,445	404	3,261	4,868	3,336	2,813	0	31	0	284	-3	-67	832	-7	198	-9,887	-2,407	-89	-1,779	13	0	0	150	100	0	3,135	1,325	150	320	1,150	382	5,000	3,480	2,793	895	18,000	17,250	14,620	21,500	19,220	11,350	16,565
Cash paid for operating lease liabilities
8,949	-	-	-	8,983	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for finance lease liabilities
499	-	-	-	384	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental Disclosures of Non-Cash Activity:
Right of use assets obtained in exchange for operating lease liabilities
6,437	-	-	-	91,743	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Right of use assets obtained in exchange for finance lease liabilities
254	-	-	-	808	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reductions to right of use assets resulting from reductions to operating lease liabilities
159	-	-	-	625	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Sale) acquistion of noncontrolling interests
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-167	145	0	167	15,931	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-